New online course on EASL Campus – HCC: Management of the side effects of immune checkpoint inhibitors
The HCC: Management of the side effects of immune checkpoint inhibitors course* is now available on EASL Campus. Course description : In this fascinating discussion, four of the leading experts in the field…
Survey: Lancet-EASL Commission on the care of liver cancer patients in Europe
The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and…
LITMUS – Progress towards diagnosing and better treating liver disease
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also…
EASL opens call for new Scientific Committee member
EASL, the European Association for the Study of the Liver, is now calling for nominations for a new Scientific Committee member to join the Governing Board for a 3 year term starting…
Call for school proposals from EASL members
Call for schools 2021 EASL would like to provide its members with the ability to participate by opening a call for programme outline proposals and proposed topics. In 2021, EASL plans to…
New Editor-in-Chief for EASL’s Journal of Hepatology
Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL) Prof. Paolo Angeli was selected…
EASL Lancet commission – Autoimmune Liver Disease in Europe – Patient Survey
Health care professionals and patient groups are working together to find out more about the experience of patients with autoimmune liver conditions across Europe. The results of this survey will be used…